Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis

A. Pardanani; J. Gotlib; A. W. Roberts; M. Wadleigh; S. Sirhan; J. Kawashima; J. A. Maltzman; L. Shao; V. Gupta; A. Tefferi

doi:10.1038/leu.2017.330

Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis

A. Pardanani, J. Gotlib, A. W. Roberts, M. Wadleigh, S. Sirhan, J. Kawashima, J. A. Maltzman, L. Shao, V. Gupta, A. Tefferi

Hematology

Research output: Contribution to journal › Letter › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	1034-1037
Number of pages	4
Journal	Leukemia
Volume	32
Issue number	4
DOIs	https://doi.org/10.1038/leu.2017.330
State	Published - Apr 1 2018

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2017.330

Cite this

@article{3748694569e049f2a2a95700e914a2f7,

title = "Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis",

author = "A. Pardanani and J. Gotlib and Roberts, {A. W.} and M. Wadleigh and S. Sirhan and J. Kawashima and Maltzman, {J. A.} and L. Shao and V. Gupta and A. Tefferi",

year = "2018",

month = apr,

day = "1",

doi = "10.1038/leu.2017.330",

language = "English (US)",

volume = "32",

pages = "1034--1037",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis

AU - Pardanani, A.

AU - Gotlib, J.

AU - Roberts, A. W.

AU - Wadleigh, M.

AU - Sirhan, S.

AU - Kawashima, J.

AU - Maltzman, J. A.

AU - Shao, L.

AU - Gupta, V.

AU - Tefferi, A.

PY - 2018/4/1

Y1 - 2018/4/1

UR - http://www.scopus.com/inward/record.url?scp=85044658778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044658778&partnerID=8YFLogxK

U2 - 10.1038/leu.2017.330

DO - 10.1038/leu.2017.330

M3 - Letter

C2 - 29263442

AN - SCOPUS:85044658778

SN - 0887-6924

VL - 32

SP - 1034

EP - 1037

JO - Leukemia

JF - Leukemia

IS - 4

ER -

Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this